Health
What’s the Valneva COVID-19 vaccine, the French shot that’s supposed to be ‘variant proof’? – The Conversation AU
It sounds too good to be true, a vaccine that can protect against future virus variants. But governments around the world are keen to learn more.
A COVID-19 vaccine from French company Valneva has yet to complete clinical trials. But it has caught the eye of governments in the UK, Europe and Australia.
One of the vaccines main selling points is its apparent ability to mount a more general immune response against SARS-CoV-2, the virus that causes COVID-19, rather than rely on the spike protein to do this.
This means the vaccine is more likely to be effective against the type of virus variants weve already seen emerging, and may emerge in…
-
General23 hours agoAustralian economy still vulnerable to US bond turmoil
-
General8 hours agoDemocratic senators want an investigation into potential market manipulation from Trump’s inner circle
-
Business19 hours agoWhat I’d buy before the ASX rebounds: 3 high-conviction share picks
-
Noosa News7 hours agoMotorbike rider dies after car collision at Kidaman Creek, west of Sunshine Coast